FREHY (Fresh2 Group) EPS (Diluted): $-33.71 (TTM As of Jun. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FREHY Fresh2 Group Ltd FREHY
12 GF Score
Price $0.00
View Full Analysis

What is Fresh2 Group EPS (Diluted)?

Fresh2 Group FREHY 12 EPS (Diluted) is $-33.71 as of Jun. 2023. GuruFocus rates FREHY with a GF Score™ of 12/100.

Fresh2 Group's Earnings per Share (Diluted) for the six months ended in Jun. 2023 was $-15.92. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was $-33.71.

Fresh2 Group's EPS (Basic) for the six months ended in Jun. 2023 was $-15.92. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2023 was $-33.71.

Fresh2 Group's EPS without NRI for the six months ended in Jun. 2023 was $-9.78. Its EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2023 was $-60.04.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

Fresh2 Group  (OTCPK:FREHY) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Fresh2 Group EPS (Diluted) Related Terms

Fresh2 Group EPS (Diluted) Historical Data

* Premium members only.

The historical data trend for Fresh2 Group's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fresh2 Group EPS (Diluted) Chart

Fresh2 Group Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
EPS (Diluted)
Get a 7-Day Free Trial -89.82 -292.03 -219.90 -273.81 -76.31

Fresh2 Group Semi-Annual Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -142.57 -130.00 -60.94 -17.79 -15.92

FREHY vs NTRB, LSTA, TFFP: EPS (Diluted) Comparison

For the Diagnostics & Research subindustry, Fresh2 Group's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fresh2 Group PE Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Fresh2 Group's PE Ratio distribution charts can be found below:

* The bar in red indicates where Fresh2 Group's PE Ratio falls into.


FREHY
12GF Score
Fresh2 Group Ltd FREHY
EPS (Diluted) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fresh2 Group EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Fresh2 Group's Diluted EPS for the fiscal year that ended in Dec. 2022 is calculated as

Diluted EPS (A: Dec. 2022 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-14.615-0)/0.191
=-76.52

Fresh2 Group's Diluted EPS for the quarter that ended in Jun. 2023 is calculated as

Diluted EPS (Q: Jun. 2023 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-9.881-0)/0.622
=-15.89

EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-33.71

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Diluted) →
What does a EPS (Diluted) of $-33.71 mean?
Fresh2 Group (FREHY) has a EPS (Diluted) of $-33.71 as of Jun. 2023. Earnings per share (diluted) equals net income divided by the diluted average shares outstanding. View historical data on Fresh2 Group and its competitors.
Is Fresh2 Group's EPS (Diluted) too high?
Fresh2 Group's current EPS (Diluted) is $-33.71. Overall, Fresh2 Group has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Fresh2 Group's EPS (Diluted) compare to NTRB and LSTA?
Fresh2 Group's EPS (Diluted) of $-33.71 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Diluted) for a Medical Diagnostics & Research company?
A good EPS (Diluted) depends on the Medical Diagnostics & Research industry context. However, EPS (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Diluted) mean?
A high EPS (Diluted) can signal that a stock is expensive relative to its fundamentals. Earnings per share (diluted) equals net income divided by the diluted average shares outstanding. View historical data on Fresh2 Group and its competitors. Fresh2 Group's current EPS (Diluted) is $-33.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fresh2 Group stock overvalued right now?
Fresh2 Group (FREHY) has a current EPS (Diluted) of $-33.71. The current EPS (Diluted) is $-33.71. Fresh2 Group's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Diluted) calculated?
EPS (Diluted) is calculated from a company's financial statements. For Fresh2 Group (FREHY), the current EPS (Diluted) is $-33.71 as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Fresh2 Group Business Description

Address 650 5TH Avenue, Street 2416, NEW YORK, NY, USA, 10019-6108
Fresh2 Group Ltd is a biotechnology company. It focuses on early cancer screening and detection. The company markets and sells a multi-cancer screening and detection test that uses its innovative patented CDA technology and its proprietary CDA device. In addition to early cancer screening and detection, its CDA technology has demonstrated the potential to assist physicians in cancer diagnosis, prognosis, and recurrence.
12GF Score

Get the complete analysis for FREHY

EPS (Diluted) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price